Skip to main content
Jennifer Ligibel, MD, Oncology, Boston, MA, Dana-Farber Cancer Institute

JenniferALigibelMD

Oncology Boston, MA

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Dr. Ligibel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ligibel's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1999
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1996

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2009 - Present
  • MA State Medical License
    MA State Medical License 1999 - 2026
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • BWEL and Beyond: Examining the Diet and Exercise Interventions on Reducing Breast Cancer Recurrences 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
  • Diet and Exercise: Role in Primary Cancer Prevention and Cancer Recurrence 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with earl... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Join now to see all

Press Mentions

  • Phase 3 Studies for Rectal, Brain, and Kidney Cancers to Be Presented by Dana-Farber Researchers at ASCO 2023
    Phase 3 Studies for Rectal, Brain, and Kidney Cancers to Be Presented by Dana-Farber Researchers at ASCO 2023May 26th, 2023
  • Lack of Financial Comfort Linked to Weight Gain Among Young Breast Cancer Survivors
    Lack of Financial Comfort Linked to Weight Gain Among Young Breast Cancer SurvivorsSeptember 11th, 2022
  • Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer Patients
    Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer PatientsJune 22nd, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations